Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome ...
H.C. Wainwright raised the firm’s price target on Soleno Therapeutics (SLNO) to $100 from $70 and keeps a Buy rating on the shares after the ...
Mum-of-five Katie Price isn’t spending Mother’s Day with her children this year—but there’s a reason. The reality TV star, 46 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback